BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:32 PM
 | 
Jul 30, 2007
 |  BC Extra  |  Company News

FDA approves EvaMist

FDA approved an NDA for EvaMist from Vivus (VVUS) to treat moderate to severe vasomotor symptoms due to menopause....

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >